Back

Asymmetric dimethylarginine (ADMA) predicts altitude-associated hypoxic pulmonary arterial hypertension

3 September 2019 (14:00 - 18:00)
Organised by:
Congress Presentation Part of: Poster Session 7 - Other aspects in Valvular Heart Disease and in pulmonary hypertension Pulmonary Hypertension ESC Premium Access ESC Congress 2019

About the speaker

Photo
Professor Rainer H Boeger

The University Medical Center Hamburg-Eppendorf, Hamburg (Germany)

11 More presentations in this session

Presentation thumbnail
Doctor A. Vijiiac (Bucharest, RO)
Abstract
Presentation thumbnail
Ms L. Rodriguez (Barcelona, ES)
Abstract
Presentation thumbnail
Associate Professor R. Kockova (Hradec Kralove, CZ)
Abstract Slides
Presentation thumbnail
Doctor K. El Chilali (Recklinghausen, DE)
Abstract
Presentation thumbnail

Access the full session

Session thumbnail
Poster Session 7 - Other aspects in Valvular Heart Disease and in pulmonary hypertension

The Event

Event poster

ESC Congress 2019

3 September 2019 14:00 CET
You may be interested in
thumbnail
Congress Presentation
AD-9308 ameliorates the impacts of 4-HNE on the progress of pulmonary arterial hypertension in aldehyde dehydrogenase 2*1*2 knock-in mice
26 August 2022
thumbnail
Congress Presentation
Gender and BMI difference in cardiopulmonary response in a general unselected population with acute exposure to high altitude: a screening study on a large cohort of subjects
30 June 2021
thumbnail
Congress Presentation
SDMA correlates with platelet reactivity and bleeding risk in patients with acute coronary syndrome undergoing percutaneous coronary intervention
29 June 2021
thumbnail
Congress Presentation
Progression of pulmonary arterial systolic pressure after chemotherapy is a poor prognostic factor in patients with multiple myeloma
20 June 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources